Greenwood Capital Associates’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,498
Closed -$2.83M 304
2025
Q4
$2.83M Sell
14,498
-400
-3% -$95.2K 0.31% 91
2025
Q3
$4.19M Sell
14,898
-28,539
-66% -$7.27M 0.48% 68
2025
Q2
$9.5M Sell
43,437
-8,507
-16% -$1.37M 1.18% 19
2025
Q1
$7.26M Buy
51,944
+6,440
+14% +$1.05M 0.98% 28
2024
Q4
$7.58M Buy
45,504
+5,090
+13% +$904K 0.99% 30
2024
Q3
$6.89M Buy
40,414
+24,169
+149% +$3.5M 0.9% 38
2024
Q2
$2.29M Buy
+16,245
New +$2.02M 0.3% 87
2021
Q2
Sell
-33,821
Closed -$2.37M 226
2021
Q1
$2.37M Buy
+33,821
New +$2.19M 0.37% 67
2018
Q2
Sell
-86,126
Closed -$3.94M 217
2018
Q1
$3.94M Buy
86,126
+5,245
+6% +$261K 0.96% 45
2017
Q4
$3.82M Buy
80,881
+6,444
+9% +$316K 0.89% 44
2017
Q3
$3.6M Buy
+74,437
New +$3.7M 0.89% 47
2013
Q3
Sell
-66,568
Closed -$2.04M 109
2013
Q2
$2.04M Buy
+66,568
New +$2.21M 0.89% 56

Other funds holding ORCL

Greenwood Capital Associates's ORCL Position: Q1 2026 in Review

Greenwood Capital Associates sold out of Oracle (ORCL) in Q1 2026, closing a stake of 14,498 shares — an estimated $2.83M sold.

Greenwood Capital Associates first reported a position in ORCL in Q2 2013 and held it in 12 quarters. The position peaked at $9.5M in Q2 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Greenwood Capital Associates reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Greenwood Capital Associates sold 14,498 Oracle shares in Q1 2026, an estimated $2.83M.
  • Greenwood Capital Associates first reported a position in Oracle in Q2 2013 and held it in 12 quarters.
  • Greenwood Capital Associates's Oracle position peaked at $9.5M in Q2 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Greenwood Capital Associates's 13F filing for Q1 2026, filed 29 Apr 2026.